The two closely related forkhead/winged helix transcription factors, Foxc1 (Mf1) and Foxc2 (Mfh1), are expressed in overlapping populations of cells contributing to endothelial cells of the heart and blood vessels and mesenchyme of the valves, outflow tract and aortic arches. We have shown that mice homozygous for null mutations in either Foxc1 or Foxc2 die pre- or perinatally with the same spectrum of cardiovascular defects, including interruption or coarctation of the aortic arch and ventricular septal defects. Most compound heterozygous mutant side with similar defects, leading to the central hypotheses that the two genes interact to regulate cardiovascular development, either through co-operative but non-identical functions, or strictly through dosage of the two gene products in the same. Using specific antibodies, we will determine the temporal and cellular localization of Foxc1 and Foxc2 protein in endothelial and neural crest mesenchyme during normal cardiovascular development (Aim 1), including coronary vessel development. The proposed hypothesis will be tested by analyzing the phenotype of more severe compound mutants and comparing these with single mutant phenotypes (Aim 2, 3). Finally, we will generate mutant mice in which Foxc1 is replaced with Foxc2 and vice versa to test if the two genes are interchangeable in vivo (Aim 2, 3).
This aim will also generate conditional mutant alleles for deleting both genes in neural crest and epicardially-derived cells (Aim 2, 3).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL067105-01
Application #
6455244
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Criswell, Tracy L; Dumont, Nancy; Barnett, Joey V et al. (2008) Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells. Cancer Res 68:7304-12
Hayashi, Hisaki; Kume, Tsutomu (2008) Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3:e2401
Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon et al. (2008) The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 283:23791-800
Hayashi, Hisaki; Kume, Tsutomu (2008) Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun 367:584-9
Austin, Anita F; Compton, Leigh A; Love, Joseph D et al. (2008) Primary and immortalized mouse epicardial cells undergo differentiation in response to TGFbeta. Dev Dyn 237:366-76
Compton, Leigh A; Potash, Dru A; Brown, Christopher B et al. (2007) Coronary vessel development is dependent on the type III transforming growth factor beta receptor. Circ Res 101:784-91
Fujita, Hideo; Kang, Myengmo; Eren, Mesut et al. (2006) Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression. Circ Res 98:626-34
Smith, Travis K; Bader, David M (2006) Characterization of Bves expression during mouse development using newly generated immunoreagents. Dev Dyn 235:1701-8
Compton, Leigh A; Potash, Dru A; Mundell, Nathan A et al. (2006) Transforming growth factor-beta induces loss of epithelial character and smooth muscle cell differentiation in epicardial cells. Dev Dyn 235:82-93
Seo, Seungwoon; Fujita, Hideo; Nakano, Atsushi et al. (2006) The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 294:458-70

Showing the most recent 10 out of 23 publications